Global Serum Separation Gel Market is Segmented By Product Type ( Serum Separation Gel Integrated with Tube, Serum Separation Gel without Tubes), By End-users ( Hospitals, Blood Bank, Pharmaceutical & Biotechnology Companies, Others), By Region (North America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Serum Separation Gel Market Overview
The global serum separation gel market is estimated to reach at a CAGR of 4.7% during the forecast period (2024-2031).
Serum separation gels are substances used to separate a blood clot from serum with greater stability and consistency to reduce clinical test outcomes. The majority of them are found in serum separation tubes (SSTs), used to collect blood samples for clinical chemistry testing.
Source: DataM Intelligence Analysis (2021)
Serum Separation Gel Market Dynamics
An increase in the number of blood banks is expected to drive market growth.
Serum separation tubes (SSTs) consist of polymer gel and spray-coated silica for serum separation. These tubes are used for serum determination in serology, chemistry, immunology and other diagnostic tests. During the centrifugation process, the gel creates a barrier between the serum and blood cells, thus providing access to the serum. According to the National Center for Biotechnology Information, approximately 2,400 institutions (community, regional, and ARC blood centers; hospital blood banks; and hospital transfusion services are present in the US. Therefore, increasing blood banks increases demand for serum separation gel, which is expected to drive market growth in the forecast period.
Restraint:
Highly expensive serum separation gel tubes, disruptive technologies to synthesize the polymers used as serum separation gels, can incur a huge loss for manufacturers. The slow clinical composition of the serum separation gel is likely to make the clinical assay complicated to interact with the blood ingredients are some of the factors that the market is expected to hamper in the forecast period.
COVID-19 Impact Analysis On Serum Separation Gel Market
The coronavirus disease 2019 (COVID-19) affected millions of people worldwide and caused disruptions at the global level, including in healthcare provision. The pandemic has led to an overall reduction of blood transfusion activities in most countries in the region, particularly blood donations, blood demands and use in health facilities. However, the experience and measures implemented by countries to overcome the reduced activities and gain the confidence of donors in safe blood donation yielded results. Moreover, pharmaceutical companies, medical device manufacturers rely heavily on healthcare facilities for their clinical trial data collection. The consistent virus spread has significantly obstructed the supply chain. The pandemic is not likely to have long-term effects on end-users primary growth in the serum separation gel market.
Serum Separation Gel Market Segment Analysis
Serum separation gel integrated with tube segment is expected to hold the largest market share in the serum separation gel market
The serum separation gel integrated with the tube segment accounted for the largest market share in 2020. The segment growth is due to the advantages such as higher resistance to irradiation, lower interference on clinical test results, huge demand for increased application of these tubes, and convenience sample handling provided for the application are some of the factors due to which the segment is expected to hold the largest market share in the forecast period.
Source: DataM Intelligence Analysis (2021)
Serum Separation Gel Market Geographical Analysis
North America region holds the largest market share in the global serum separation gel market
In 2020, North America accounted for the highest revenue share. The increasing prevalence of hematological disorders and various infectious diseases, rising investments in research & development, and the advantage of gel tubes in testing for thyroid function are expected to boost the market in the forecast period. For instance, the prevalence of iron deficiency in patients with chronic heart failure has been reported to be as high as 50%. Heart Failure (HF) patients with iron deficiency experience decreased aerobic performance, increased exercise intolerance, reduced functional status, increased hospitalization and readmission rates, and increased mortality. Iron deficiency (ID) is also an independent predictor of mortality. Some studies report that ID has greater predictive power than anemia for mortality and adverse disease outcomes among patients with HF. Traditionally, the presence of ID was only considered clinically relevant in the presence of anemia. However, with iron deficiency being the most common cause of anemia in the population, anemia probably reflects an overt extreme of severe iron deficiency that impacts hemoglobin and red cell production. Moreover, the rising preference for digital healthcare services among the public to access personal health and fitness in the region contributes to its outstanding share in the market growth.
Source: DataM Intelligence Analysis (2021)
Serum Separation Gel Market Competitive Landscape
Major key players in the serum separation gel market are Cardinal Health, Inc., InterVacTechnology OU, Becton Dickinson & Company, Greiner Bio-One International GmbH, Sekisui Diagnostics, Art Robbins Instruments, LLC, Hunan Liuyang Medical Instrument Factory, Chongqing New World Trading Co., Ltd. and Caremax Co., Ltd.
Cardinal Health, Inc.:
Overview:
Cardinal Health, Inc. is based in Dublin, Ohio, and was formed in 1979. Pharmaceutical and Medical are the two segments in which the company operates. The pharmaceutical segment distributes branded and generic pharmaceuticals, speciality pharmaceuticals, and over-the-counter healthcare and consumer items. Cardinal Health branded medical, surgical, and laboratory equipment and devices are manufactured, sourced, and distributed by the Medical segment. Moreover, the company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centres, clinical laboratories, physician offices, and patients in the home. It has a collaboration agreement with Journey Biosciences, Inc., and the company is operated in operations in more than 35 countries and has approximately 44,000 employees globally.
Product Portfolio:
Corvac™: Corvac™ integrated serum separator tubes are silicone coated tubes with new Crown Corvac™ gel placement for improved performance and more sample yield for laboratory procedures requiring serum with a positive gel barrier between blood cells and serum.
Why Purchase the Report?
- Visualize the composition of the global serum separation gel market segmentation by product type, end-users and region highlighting the key commercial assets and players.
- Identify commercial opportunities in the global serum separation gel market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of global serum separation gel market-level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global serum separation gel market report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.
